The effect of mitoxantrone on prostate cancer and analysis of pain relief
10.3969/j.issn.1005-1678.2017.06.060
- VernacularTitle:米托蒽醌对前列腺癌骨痛缓解情况、临床疗效及安全性分析
- Author:
Hu YI
;
Ming ZHAO
;
Jinhua HE
- Keywords:
mitoxantrone;
prostate cancer;
sleep quality;
tumor markers
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(6):161-163
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the therapeutic effect of mitoxantrone on prostate cancer and the effect of relieving pain of patients.MethodsRetrospective analysis of clinical data of patients with bone pain in April 2010 to May 2016 year in our hospital for treatment of prostate cancer, according to their treatment divided into control group and observation group, the control group was 40 cases given docetaxel treatment, the observation group was 30 cases treated with mitoxantrone.Compared the pain relief, sleep quality, tumor markers and the incidence of adverse reactions of the two groups.ResultsAfter treatment, the observation group pain control rate was 96.67%, significantly higher than the control group, the difference was statistically significant (P<0.05);the observation group sleep quality was significantly better than the control group, the difference was statistically significant (P<0.05);the observation group cPSA and CEA were lower than those of control group, the difference was statistically significant (P<0.05).Two groups of patients with bone marrow suppression, nausea and vomiting, rash and liquid retention rate had no significant difference (χ2=0.648, P=0.421).ConclusionMitoxantrone has better therapeutic effect on prostate cancer, can significantly relieve the situation and quality of sleep in patients with bone pain.
